Search
06/09/2023
EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: State of the art 2023
Krausz, C, Navarro-Costa, P, Wilke, M, Tüttelmann, F. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: State of the art 2023. Andrology. 2023; DOI:10.1111/andr.13514. PMID:37674303. IF:3.200(Q1/3D).
03/09/2023
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos-Ruiz R, Dittmann A, Nanni P, Fresno Vara JÁ, Espinosa E. Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.. Cancers. 2023; 15(17)DOI:10.3390/cancers15174407. PMID:37686682. IF:4.500(Q1/3D).
01/09/2023
Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients
Mazuecos, A, Villanego, F, Alonso, A, Beneyto, I, Crespo, M, Diaz-Corte, C, Franco, A, Gonzalez-Roncero, F, Guirado, L, Jimenez, C, Juega, J, Llorente, S, Paul, J, Rodriguez-Benot, A, Ruiz, JC, Sanchez-Fructuoso, A, Torregrosa, V, Rodrigo, E, Hernandez, D, Lopez, V, Lopez-Oliva, M, Zarraga, S. Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients. NEFROLOGIA. 2023; 43(5)DOI:10.1016/j.nefro.2022.11.001. PMID:37957107. IF:2.000(Q2/5D).
01/09/2023
Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients
Espanol, P, Rovira, R, Caruana, P, Luna-Guibourg, R, Soler, C, Teixeira, N, Rodriguez, F, Gallardo, A, Edwards, M, Porta, O, Gamez, M, Sanchez, O, Llurba, E, Corchero, JL, Cespedes, MV. Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients. GYNECOLOGIC ONCOLOGY. 2023; 176DOI:10.1016/j.ygyno.2023.06.019. PMID:37437489. IF:4.500(Q1/1D).
01/09/2023
An institutional study: Does Body Mass Index influence surgical approach, surgical morbidities, and outcomes in endometrial cancer patients?
Espanol, P, Luzarraga, A, Teixeira, N, Soler, C, Luna-Guibourg, R, Rovira, R. An institutional study: Does Body Mass Index influence surgical approach, surgical morbidities, and outcomes in endometrial cancer patients?. Facts Views And Vision In Obgyn. 2023; 15(3)DOI:10.52054/FVVO.15.3.081. PMID:37742203. IF:(Q/D).
01/09/2023
Identifying most important contextual factors for the implementation of self-management interventions: A Delphi study
Noordman, J, Heijmans, M, Poortvliet, R, Groene, O, Ballester, M, Ninov, L, de Guzman, EN, Alonso-Coello, P, Orrego, C, Sunol, R, Wagner, C. Identifying most important contextual factors for the implementation of self-management interventions: A Delphi study. PATIENT EDUCATION AND COUNSELING. 2023; 114DOI:10.1016/j.pec.2023.107843. PMID:37352753. IF:2.900(Q2/4D).